fludarabine has been researched along with Proteinuria in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giannakakis, C; Guido, G; Mosillo, G; Rocca, AR; Salviani, C; Serriello, I | 1 |
| Austin, H; Balow, JE; Barrett, J; Childs, R; Geller, N; Igarashi, T; Lundqvist, A; Sabnis, S; Srinivasan, R; Takahashi, Y; Tisdale, J | 1 |
| Austin, HA; Balow, JE; Boumpas, DT; Chitkara, P; Fleisher, T; Illei, GG; Klippel, JH; Kuroiwa, T; Schlimgen, R; Tisdale, JF; Yarboro, CH | 1 |
| Austin, HA; Balow, JE; Boumpas, DT; Fleisher, TA; Kim, Y; Piscitelli, S; Pucino, F; Tassiulas, IO; Vaughan, E | 1 |
| Abdel-Raheem, MM; Gross, GG; Jamil, MG; Potti, A | 1 |
1 review(s) available for fludarabine and Proteinuria
| Article | Year |
|---|---|
Fludarabine in chronic lymphocytic leukemia with membranous nephropathy.
Topics: Aged; Antineoplastic Agents; Biopsy, Needle; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Proteinuria; Rare Diseases; Risk Assessment; Treatment Outcome; Vidarabine | 2013 |
1 trial(s) available for fludarabine and Proteinuria
| Article | Year |
|---|---|
Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
Topics: Adult; Aged; CD4 Lymphocyte Count; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Lymphopenia; Male; Middle Aged; Neutropenia; Pilot Projects; Proteinuria; Treatment Outcome; Vidarabine | 2007 |
3 other study(ies) available for fludarabine and Proteinuria
| Article | Year |
|---|---|
Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cyclophosphamide; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; T-Lymphocytes; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2005 |
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
Topics: Adult; Alkylating Agents; Anti-Inflammatory Agents; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunoglobulin G; Immunologic Memory; Immunosuppressive Agents; Lupus Nephritis; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Pilot Projects; Prednisone; Proteinuria; Renal Plasma Flow, Effective; Sinusitis; Vidarabine | 1999 |
Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
Topics: Antineoplastic Agents; Diagnosis, Differential; Female; Glomerulonephritis, Membranous; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Nephrotic Syndrome; Proteinuria; Remission Induction; Treatment Outcome; Vidarabine | 2000 |